Defining endothelial progenitor cells

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Human cord blood-derived endothelial progenitor cells (EPC) have been defined as circulating cells that express a panel of cell surface markers similar to those known to be expressed by vascular endothelial cells, that home to sites of hypoxia/ischemia upon infusion into experimental animal models, and participate in blood vessel formation (as analyzed by in vitro and in vivo methods). Although no specific marker for an EPC has been identified, a group of markers has been consistently utilized as a surrogate marker for cells purported to display vascular regenerative capacity. Since both hematopoietic and vascular endothelial subsets display many of the same cell surface antigens and both participate in new blood vessel formation, recent analyses have stressed the need to reconsider the use of the term EPC. This chapter reviews our current approaches to identifying human EPC and provides a brief summary statement for a new definition of an EPC.

Original languageEnglish (US)
Title of host publicationRegenerative Therapy Using Blood-Derived Stem Cells
PublisherHumana Press Inc.
Pages9-19
Number of pages11
ISBN (Electronic)9781617794711
ISBN (Print)9781617794704
DOIs
StatePublished - Jan 1 2012

Fingerprint

Endothelial cells
Blood Vessels
Blood vessels
Surface Antigens
Fetal Blood
Ischemia
Endothelial Cells
Animal Models
Biomarkers
Endothelial Progenitor Cells
Animals
Blood

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Mund, J., Ingram, D., & Yoder, M. (2012). Defining endothelial progenitor cells. In Regenerative Therapy Using Blood-Derived Stem Cells (pp. 9-19). Humana Press Inc.. https://doi.org/10.1007/978-1-61779-471-1_2

Defining endothelial progenitor cells. / Mund, Julie; Ingram, David; Yoder, Mervin.

Regenerative Therapy Using Blood-Derived Stem Cells. Humana Press Inc., 2012. p. 9-19.

Research output: Chapter in Book/Report/Conference proceedingChapter

Mund, J, Ingram, D & Yoder, M 2012, Defining endothelial progenitor cells. in Regenerative Therapy Using Blood-Derived Stem Cells. Humana Press Inc., pp. 9-19. https://doi.org/10.1007/978-1-61779-471-1_2
Mund J, Ingram D, Yoder M. Defining endothelial progenitor cells. In Regenerative Therapy Using Blood-Derived Stem Cells. Humana Press Inc. 2012. p. 9-19 https://doi.org/10.1007/978-1-61779-471-1_2
Mund, Julie ; Ingram, David ; Yoder, Mervin. / Defining endothelial progenitor cells. Regenerative Therapy Using Blood-Derived Stem Cells. Humana Press Inc., 2012. pp. 9-19
@inbook{a9d21de4eef549b095af9b473b201a63,
title = "Defining endothelial progenitor cells",
abstract = "Human cord blood-derived endothelial progenitor cells (EPC) have been defined as circulating cells that express a panel of cell surface markers similar to those known to be expressed by vascular endothelial cells, that home to sites of hypoxia/ischemia upon infusion into experimental animal models, and participate in blood vessel formation (as analyzed by in vitro and in vivo methods). Although no specific marker for an EPC has been identified, a group of markers has been consistently utilized as a surrogate marker for cells purported to display vascular regenerative capacity. Since both hematopoietic and vascular endothelial subsets display many of the same cell surface antigens and both participate in new blood vessel formation, recent analyses have stressed the need to reconsider the use of the term EPC. This chapter reviews our current approaches to identifying human EPC and provides a brief summary statement for a new definition of an EPC.",
author = "Julie Mund and David Ingram and Mervin Yoder",
year = "2012",
month = "1",
day = "1",
doi = "10.1007/978-1-61779-471-1_2",
language = "English (US)",
isbn = "9781617794704",
pages = "9--19",
booktitle = "Regenerative Therapy Using Blood-Derived Stem Cells",
publisher = "Humana Press Inc.",

}

TY - CHAP

T1 - Defining endothelial progenitor cells

AU - Mund, Julie

AU - Ingram, David

AU - Yoder, Mervin

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Human cord blood-derived endothelial progenitor cells (EPC) have been defined as circulating cells that express a panel of cell surface markers similar to those known to be expressed by vascular endothelial cells, that home to sites of hypoxia/ischemia upon infusion into experimental animal models, and participate in blood vessel formation (as analyzed by in vitro and in vivo methods). Although no specific marker for an EPC has been identified, a group of markers has been consistently utilized as a surrogate marker for cells purported to display vascular regenerative capacity. Since both hematopoietic and vascular endothelial subsets display many of the same cell surface antigens and both participate in new blood vessel formation, recent analyses have stressed the need to reconsider the use of the term EPC. This chapter reviews our current approaches to identifying human EPC and provides a brief summary statement for a new definition of an EPC.

AB - Human cord blood-derived endothelial progenitor cells (EPC) have been defined as circulating cells that express a panel of cell surface markers similar to those known to be expressed by vascular endothelial cells, that home to sites of hypoxia/ischemia upon infusion into experimental animal models, and participate in blood vessel formation (as analyzed by in vitro and in vivo methods). Although no specific marker for an EPC has been identified, a group of markers has been consistently utilized as a surrogate marker for cells purported to display vascular regenerative capacity. Since both hematopoietic and vascular endothelial subsets display many of the same cell surface antigens and both participate in new blood vessel formation, recent analyses have stressed the need to reconsider the use of the term EPC. This chapter reviews our current approaches to identifying human EPC and provides a brief summary statement for a new definition of an EPC.

UR - http://www.scopus.com/inward/record.url?scp=85024915968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024915968&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-471-1_2

DO - 10.1007/978-1-61779-471-1_2

M3 - Chapter

AN - SCOPUS:85024915968

SN - 9781617794704

SP - 9

EP - 19

BT - Regenerative Therapy Using Blood-Derived Stem Cells

PB - Humana Press Inc.

ER -